Cargando…
Clofazimine: A Promising Inhibitor of Rabies Virus
With an almost 100% mortality rate, rabies virus (RABV) infection is a global concern. Limited post-exposure prophylaxis and lack of an effective treatment necessitate novel antiviral therapies against RABV. Here, using a high-throughput screening (HTS) method developed in our lab, 11 candidates wit...
Autores principales: | Wu, Jiajing, Cao, Shouchun, Lei, Shan, Liu, Qiang, Li, Yinghong, Yu, Yueyang, Xie, Hui, Li, Qianqian, Zhao, Xiaoqiang, Chen, Ruifeng, Huang, Weijin, Xiao, Xinyue, Yu, Yongxin, Song, Danqing, Li, Yuhua, Wang, Youchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012719/ https://www.ncbi.nlm.nih.gov/pubmed/33815101 http://dx.doi.org/10.3389/fphar.2021.598241 |
Ejemplares similares
-
Clofazimine derivatives as potent broad-spectrum antiviral agents with dual-target mechanism
por: Zhang, Xintong, et al.
Publicado: (2022) -
Antigenic variations of recent street rabies virus
por: Wang, Wenbo, et al.
Publicado: (2019) -
Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system
por: Nie, Jianhui, et al.
Publicado: (2017) -
Clofazimine for the treatment of tuberculosis
por: Stadler, Jacob A. M., et al.
Publicado: (2023) -
Analysis of the evolution, infectivity and antigenicity of circulating rabies virus strains
por: Cai, Meina, et al.
Publicado: (2022)